SCHEMBL26833489

SCHEMBL26833489

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ncc8ccccc8n7)cc6)c6ccc(-c7ncc8ccccc8n7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.56
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ RECQL P46063 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ PIK3CD O00329 2/20 0.37
▸ PIK3CA P42336 2/20 0.37
▸ MTOR P42345 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ GPR3 P46089 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ PIK3CG P48736 1/20 0.36
▸ CYP11B1 P15538 2/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ CYP17A1 P05093 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ BIRC5 O15392 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26834065 0.94 CYP1A2 (0.54) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL26834163 0.91 CYP1A2 (0.51) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL26833831 0.89 CYP1A2 (0.45) CYP1A2MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL26833661 0.88 MAPT (0.60) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL26833600 0.86 KDM4E (0.47) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL26833448 0.86 PDGFRB (0.50) NPC1RAB9APIK3CDPIK3CAMTOR
SCHEMBL26833686 0.85 SMN1; SMN2 (0.41) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL26833592 0.84 KDM4E (0.49) CYP1A2PIK3CDPIK3CAMTORKDM4E
SCHEMBL26833597 0.84 KDM4E (0.44) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL26833488 0.84 NPC1 (0.49) MAPTSMN1; SMN2NPC1RAB9APIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 CYP1A2 122/4885LMNA 502/4885MAPT 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback